These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19262660)

  • 1. Drug discovery: Not as fab as we thought.
    Zlitni S; Brown ED
    Nature; 2009 Mar; 458(7234):39-40. PubMed ID: 19262660
    [No Abstract]   [Full Text] [Related]  

  • 2. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens.
    Brinster S; Lamberet G; Staels B; Trieu-Cuot P; Gruss A; Poyart C
    Nature; 2009 Mar; 458(7234):83-6. PubMed ID: 19262672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycopeptide resistance in gram-positive pathogens.
    Fraimow HS; Shlaes DM
    Adv Exp Med Biol; 1995; 390():81-95. PubMed ID: 8718604
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Microbiology and Infectious Diseases (ECCMID)--18th European Congress. Drug resistance among Gram-negative and Gram-positive bacteria.
    Falagas ME; Karageorgopoulos DE
    IDrugs; 2008 Jun; 11(6):409-11. PubMed ID: 18509779
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.
    Mitscher LA
    Chem Rev; 2005 Feb; 105(2):559-92. PubMed ID: 15700957
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction.
    Protein Sci; 2020 Mar; 29(3):623-628. PubMed ID: 32058636
    [No Abstract]   [Full Text] [Related]  

  • 7. Importance of antibiotic resistance and resistance mechanisms. Foreword.
    Bonomo RA; Rossolini GM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):549-50. PubMed ID: 18847392
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evolution of bacterial resistance to antibiotics in México, 1973-2013].
    Rodríguez-Noriega E; León-Garnica G; Petersen-Morfín S; Pérez-Gómez HR; González-Díaz E; Morfín-Otero R
    Biomedica; 2014 Apr; 34 Suppl 1():181-90. PubMed ID: 24968050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.
    Zhong C; Liu T; Gou S; He Y; Zhu N; Zhu Y; Wang L; Liu H; Zhang Y; Yao J; Ni J
    Eur J Med Chem; 2019 Nov; 182():111636. PubMed ID: 31466017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteria: able to learn and adapt. Disease pathogens protect themselves through various resistance mechanisms].
    Heinzl S
    Med Monatsschr Pharm; 2006 Dec; 29(12):430-2. PubMed ID: 17220036
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogens resistant to antibacterial agents.
    Chen LF; Chopra T; Kaye KS
    Infect Dis Clin North Am; 2009 Dec; 23(4):817-45, vii. PubMed ID: 19909886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sortase transpeptidases: insights into mechanism, substrate specificity, and inhibition.
    Clancy KW; Melvin JA; McCafferty DG
    Biopolymers; 2010; 94(4):385-96. PubMed ID: 20593474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel antibacterials.
    Romesberg FE; Craney A
    Bioorg Med Chem; 2016 Dec; 24(24):6225-6226. PubMed ID: 27932231
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatty Acids Composition and Antibacterial Activity of Aristolochia longa L. and Bryonia dioïca Jacq. Growing Wild in Tunisia.
    Dhouioui M; Boulila A; Jemli M; Schiets F; Casabianca H; Zina MS
    J Oleo Sci; 2016 Aug; 65(8):655-61. PubMed ID: 27430383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants.
    Fluit AC; Schmitz FJ; Verhoef J; Milatovic D
    Antimicrob Agents Chemother; 2004 Mar; 48(3):1007-11. PubMed ID: 14982796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacterial enzymes inactivating aminoglycoside antibiotics and their coding genes].
    Vakulenko SB
    Antibiot Khimioter; 1992 Apr; 37(4):49-54. PubMed ID: 1329687
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of daptomycin for gram-positive infections.
    Tally FP; DeBruin MF
    J Antimicrob Chemother; 2000 Oct; 46(4):523-6. PubMed ID: 11020247
    [No Abstract]   [Full Text] [Related]  

  • 18. Nisin resistance in Gram-positive bacteria and approaches to circumvent resistance for successful therapeutic use.
    Barbosa AAT; de Melo MR; da Silva CMR; Jain S; Dolabella SS
    Crit Rev Microbiol; 2021 May; 47(3):376-385. PubMed ID: 33689548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing.
    Hecht DW
    Anaerobe; 2006 Jun; 12(3):115-21. PubMed ID: 16765857
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current state of antibiotic resistance of pathogenic aerobic bacteria in Hungary].
    Konkoly T; Marianne ; Bán E
    Orv Hetil; 1986 Apr; 127(17):995-1001. PubMed ID: 3703555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.